Anatara Lifesciences (ASX:ANR) Accounts Payable: A$0.17 Mil (As of Dec. 2025)


What is Anatara Lifesciences Accounts Payable?

Anatara Lifesciences ASX:ANR Accounts Payable is A$0.17 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Anatara Lifesciences's Accounts Payable for the quarter that ended in Dec. 2025 was A$0.17 Mil.

Anatara Lifesciences's quarterly Accounts Payable declined from Dec. 2024 (A$0.37 Mil) to Jun. 2025 (A$0.17 Mil) and declined from Jun. 2025 (A$0.17 Mil) to Dec. 2025 (A$0.17 Mil).

Anatara Lifesciences's annual Accounts Payable increased from Jun. 2023 (A$0.08 Mil) to Jun. 2024 (A$0.25 Mil) but then declined from Jun. 2024 (A$0.25 Mil) to Jun. 2025 (A$0.17 Mil).


Anatara Lifesciences Accounts Payable Related Terms


Anatara Lifesciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Anatara Lifesciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anatara Lifesciences Accounts Payable Chart

Anatara Lifesciences Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.15 0.08 0.25 0.17

Anatara Lifesciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.25 0.37 0.17 0.17

Anatara Lifesciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$0.17 Mil mean?
Anatara Lifesciences (ASX:ANR) has a Accounts Payable of A$0.17 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Anatara Lifesciences and its competitors.
Is Anatara Lifesciences' Accounts Payable too high?
Anatara Lifesciences' current Accounts Payable is A$0.17 Mil.
How does Anatara Lifesciences' Accounts Payable compare to VRTX and REGN?
Anatara Lifesciences' Accounts Payable of A$0.17 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Anatara Lifesciences and its competitors. Anatara Lifesciences's current Accounts Payable is A$0.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anatara Lifesciences stock overvalued right now?
Anatara Lifesciences (ASX:ANR) has a current Accounts Payable of A$0.17 Mil. The current Accounts Payable is A$0.17 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Anatara Lifesciences (ASX:ANR), the current Accounts Payable is A$0.17 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anatara Lifesciences Business Description

Address c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000
Anatara Lifesciences Ltd develops and commercializes evidence-based products addressing unmet needs in gastrointestinal health. The company focuses on building a pipeline of human health products, particularly targeting complex gastrointestinal conditions. It operates through a single reportable segment encompassing the research and development of oral solutions for gastrointestinal diseases and the commercialization of Detach, a diarrhea treatment for piglets.